Cart
sales@molnova.com
RV01
CAS No. 1016897-10-1
RV01( —— )
Catalog No. M33113 CAS No. 1016897-10-1
RV01 is a novel quinoline-substituted analogue of resveratrol that inhibits DNA damage, reduces ethanol-induced acetaldehyde dehydrogenase (ALDH2) mRNA expression, and has hydroxyl radical scavenging activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 144 | In Stock |
|
| 5MG | 130 | In Stock |
|
| 10MG | 207 | In Stock |
|
| 25MG | 352 | In Stock |
|
| 50MG | 498 | In Stock |
|
| 100MG | 658 | In Stock |
|
| 200MG | 891 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRV01
-
NoteResearch use only, not for human use.
-
Brief DescriptionRV01 is a novel quinoline-substituted analogue of resveratrol that inhibits DNA damage, reduces ethanol-induced acetaldehyde dehydrogenase (ALDH2) mRNA expression, and has hydroxyl radical scavenging activity.
-
DescriptionRV01 is an analogue of resveratrol, inhibits DNA damage, reduces acetaldehyde dehydrogenase 2 (ALDH2) mRNA expression induced by ethanol, and exhibits hydroxyl radical scavenging activity. RV01 decreases iNOS expression, with anti-neuroinflammatory activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
RecptorMAPK | TLR | Dehydrogenase | NF-κB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1016897-10-1
-
Formula Weight263.29
-
Molecular FormulaC17H13NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 5 mg/mL (18.99 mM; Ultrasonic )
-
SMILESOc1cc(O)cc(\C=C\c2ccnc3ccccc23)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yan Y, et al. Protection of resveratrol and its analogues against ethanol-induced oxidative DNA damage in human peripheral lymphocytes. Mutat Res. 2011 Apr 3;721(2):171-7.?
molnova catalog
related products
-
UR13870
UR-13870 (Org 48762-0) is an orally active and selective inhibitor of p38 mitogen-activated protein kinase (MAPK), which prevents bone damage in collagen-induced arthritis in mice.
-
p38α inhibitor 3
p38α inhibitor 3 is a inhibitor of the mitogen-activated protein kinase p38α that can block the effectiveness of myoblast differentiation.
-
Ro-3201195
Ro-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.
